Search Sciety

Showing page 1 of 986 pages of search results

• Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England

  This article's authors

  1. Beaney T
  2. Neves AL
  3. Alboksmaty A
  4. Flott K
  5. Fowler A
  6. Benger JR
  7. Aylin P
  8. Elkin S
  9. Darzi A
  10. Clarke J

• Google Trends as a predictive tool for COVID-19 vaccinations in Italy: a retrospective infodemiological analysis.

  This article's authors

  1. Rovetta A

• Evaluation of Vaccination Strategies for the metropolitan area of Madrid

  This article's authors

  1. Singh DE
  2. Olmedo Luceron C
  3. Limia Sanchez A
  4. Guzman-Merino M
  5. Duran C
  6. Delgado-Sanz C
  7. Gomez-Barroso D
  8. Carretero J
  9. Marinescu MC

• Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021

  This article's authors

  1. Hall VJ
  2. Foulkes S
  3. Insalata F
  4. Saei A
  5. Kirwan P
  6. Atti A
  7. Wellington E
  8. Khawam J
  9. Munro K
  10. Cole M
  11. Tranquillini C
  12. Taylor-Kerr A
  13. Hettiarachchi N
  14. Calbraith D
  15. Sajedi N
  16. Milligan I
  17. Themistocleous Y
  18. Corrigan D
  19. Cromey L
  20. Price L
  21. Stewart S
  22. de Lacy E
  23. Norman C
  24. Linley E
  25. Otter AD
  26. Semper A
  27. Hewson J
  28. D'Arcangelo S
  29. Chand MA
  30. Brown CS
  31. Brooks T
  32. Islam J
  33. Charlett A
  34. Hopkins S
  35. The SIREN Study Group

• Association of subcutaneous or intravenous route of administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in COVID-19.

  This article's authors

  1. McCreary EK
  2. Bariola JR
  3. Wadas RJ
  4. Shovel JA
  5. Wisniewski MK
  6. Adam M
  7. Albin D
  8. Minnier TE
  9. Schmidhofer M
  10. Meyers R
  11. Marroquin OC
  12. Collins K
  13. Garrard W
  14. Berrry LR
  15. Berry S
  16. Crawford AM
  17. McGlothlin A
  18. Linstrum K
  19. Nakayama A
  20. Montgomery SK
  21. Snyder GM
  22. Yealy DM
  23. Angus DC
  24. Kip PL
  25. Seymour CW
  26. Huang DT
  27. Kip KE

• AImmune: a new blood-based machine learning approach to improving immune profiling analysis on COVID-19 patients

  This article's authors

  1. Zhang XT
  2. Han RH

• Lifestyle behaviours of children and adolescents during the first two waves of the COVID-19 pandemic in Switzerland and their relation to well-being: a population-based study

  This article's authors

  1. Peralta GP
  2. Camerini A
  3. Haile SR
  4. Kahlert CR
  5. Lorthe E
  6. Marciano L
  7. Nussbaumer A
  8. Radtke T
  9. Ulyte A
  10. Puhan MA
  11. Kriemler S

• Th1, Th2 and Th17 inflammatory pathways synergistically correlate with cardiometabolic processes. A case study in COVID-19.

  This article's authors

  1. Michels JR
  2. Nazrul MS
  3. Adhikari S
  4. Wilkins D
  5. Pavel AB

• SARS-CoV-2 Virus like Particles produced by a single recombinant baculovirus generate potent neutralizing antibody that protects against variant challenge

  This article's authors

  1. Sullivan E
  2. Sung P
  3. Wu W
  4. Berry N
  5. Kempster S
  6. Ferguson D
  7. Almond N
  8. Jones IM
  9. Roy P

• A human monoclonal antibody potently pan-neutralizes SARS-CoV-2 VOCs by targeting RBD invariant sites

  This article's authors

  1. Wang X
  2. Hu A
  3. Chen X
  4. Zhang Y
  5. Yu F
  6. Yue S
  7. Li A
  8. Zhang J
  9. Pan Z
  10. Yang Y
  11. Lin Y
  12. Gao L
  13. Zhou J
  14. Zhao J
  15. Li F
  16. Shi Y
  17. Huang F
  18. Yang X
  19. Peng Y
  20. Tu L
  21. Zhang H
  22. Zheng H
  23. He J
  24. Zhang H
  25. Xu L
  26. Huang Q
  27. Zhu Y
  28. Deng K
  29. Ye L

• Peptide-antibody Fusions Engineered by Phage Display Exhibit Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants

  This article's authors

  1. Labriola JM
  2. Miersch S
  3. Chen G
  4. Chen C
  5. Pavlenco A
  6. Pisanu F
  7. Caccuri F
  8. Zani A
  9. Sharma N
  10. Feng A
  11. Leung DW
  12. Caruso A
  13. Amarasinghe GK
  14. Sidhu S

• In silico study on the effects of disulfide bonds in ORF8 of SARS-CoV-2

  This article's authors

  1. Cheng Y
  2. Peng X

• Use of heat-not-burn tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers

  This article's authors

  1. Yamamoto S
  2. Tanaka A
  3. Ohmagari N
  4. Yamaguchi K
  5. Ishitsuka K
  6. Morisaki N
  7. Kojima M
  8. Nishikimi A
  9. Tokuda H
  10. Inoue M
  11. Tanaka S
  12. Umezawa J
  13. Okubo R
  14. Nishimura K
  15. Konishi M
  16. Miyo K
  17. Mizoue T

• Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta Spike as well as Nucleocapsid Antigens

  This article's authors

  1. Rice A
  2. Verma M
  3. Voigt E
  4. Battisti P
  5. Beaver S
  6. Reed S
  7. Dinkins K
  8. Mody S
  9. Zakin L
  10. Sieling P
  11. Tanaka S
  12. Morimoto B
  13. Higashide W
  14. Olson CA
  15. Gabitzsch ER
  16. Safrit JT
  17. Spilman PR
  18. Casper C
  19. Soon-Shiong P

• Normalisation of SARS-CoV-2 concentrations in wastewater: the use of flow, conductivity and CrAssphages

  This article's authors

  1. Langeveld J
  2. Schilperoort R
  3. Heijnen L
  4. elsinga g
  5. schapendonk c
  6. fanoy e
  7. de schepper e
  8. Koopmans M
  9. de Graaf M
  10. Medema G

• Phase Shift Between Age-Specific COVID-19 Incidence Curves Points to a Potential Epidemic Driver Function of Kids and Juveniles in Germany

  This article's authors

  1. Diebner HH

• On the Role of Financial Support Programs in Mitigating the Sars-CoV-2 Spread in Brazil

  This article's authors

  1. Albani VVL
  2. Albani RAS
  3. Bobko N
  4. Massad E
  5. Zubelli JP

• Coping with COVID-19 Stressors: Adverse and Protective Factors Responding to Emotions in a Chinese Sample

  This article's authors

  1. Xu R
  2. Zhang X
  3. Liu D
  4. Li Q
  5. Wang Y
  6. Jiao R
  7. Gong X
  8. Hou X
  9. Xu T
  10. Qing X
  11. Song K
  12. Kavcic V
  13. Yan S
  14. Gu R
  15. Stratton T
  16. Jiang Y

• Effectiveness of a third dose of BNT162b2 or mRNA-1273 vaccine for preventing post-vaccination COVID-19 infection: an observational study

  This article's authors

  1. Sharma A
  2. Oda G
  3. Holodniy M

• SARS-CoV-2 Delta variant saliva viral load is 15-fold higher than wild-type strains

  This article's authors

  1. Imai K
  2. Ikeno R
  3. Tanaka H
  4. Takada N